Catalyst Wire Dossier Catalyst Wire Dossier

ExAblate Transcranial MRgFUS

MR-guided focused ultrasound · InSightec
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ExAblate Transcranial MRgFUS, covering 2022-01-19 to 2026-08-13. Get the full timeline:

Most recent: Clinical Trial Results: ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's Disease [NA]

See pricing